Skip to main content
KUKJEON PHARMACEUTICAL Co.,Ltd logo

KUKJEON PHARMACEUTICAL Co.,Ltd — Investor Relations & Filings

Ticker · 307750 ISIN · KR7307750000 KO Manufacturing
Filings indexed 325 across all filing types
Latest filing 2026-05-28 Major Shareholding Noti…
Country KR South Korea
Listing KO 307750

About KUKJEON PHARMACEUTICAL Co.,Ltd

https://www.kukjeon.co.kr/en/

KUKJEON PHARMACEUTICAL Co., Ltd. is a chemical total solution provider specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs). The company's portfolio includes raw materials for specialized medicines such as choline alfoscerates, benfothiamines, and napamostat. A key product is Itopride hydrochloride, a functional indigestion treatment, for which the company holds a proprietary manufacturing patent. In addition to its pharmaceutical focus, the company also develops and supplies chemical materials for the electronics industry.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 85% confidence The document is a Korean “주식등의 대량보유상황보고서” filed under the Capital Markets Act to disclose detailed holdings and changes by a major shareholder and related parties. It is not a company’s financial report but a notification by a shareholder of large share ownership, matching the Major Shareholding Notification category.
2026-05-28 Korean
신주인수권행사가액의조정
Share Issue/Capital Change Classification · 78% confidence The document is an official announcement detailing the adjustment of the exercise price and share quantity of existing warrants (new‐share subscription rights). It provides the pre- and post-adjustment exercise prices, the method and legal basis for adjustment, application date, and related reference filings. This is not a financial report, earnings release, or regulatory certification, but rather a capital change notification concerning warrant terms. Therefore it falls under “Share Issue/Capital Change” (SHA).
2026-05-27 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” (Quarterly Report) for the period January 1, 2026 to March 31, 2026, filed with the Financial Services Commission and the Korea Exchange. It contains detailed financial statements, business overview, capital changes, and other comprehensive interim period disclosures. This matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 92% confidence The document is a Korean ‘주식등의 대량보유상황보고서’ (Large Shareholding Report) filed with the Financial Services Commission and Korea Exchange. It details the number and percentage of shares held by the reporting person and their related parties, changes in holdings, contract details (pledges, borrowings), and reasons for the report (e.g., repayment of stock‐secured loan). This matches a Major Shareholding Notification rather than a financial report, earnings release, or management announcement.
2026-05-12 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서(약식)' which translates to 'Report on Large Shareholding Status (Abbreviated)'. It contains detailed information about shareholding changes, including the number of shares held, changes in shareholding percentages, and specifics about the reporting entity and related parties. The document references legal provisions related to large shareholding disclosures under capital market laws. It is a detailed report of share ownership changes and holdings by a significant shareholder or investment entity. This matches the definition of a Major Shareholding Notification (MRQ), which involves notification of changes in significant share ownership levels. The document is lengthy (over 12,000 characters) and contains substantive data, not just an announcement or certification. Therefore, the correct classification is MRQ with high confidence.
2026-05-07 Korean
소속부변경
Regulatory Filings Classification · 95% confidence The document is a brief announcement about a change in the company's listing segment from '우량기업부' (Excellent Enterprise Division) to '중견기업부' (Mid-sized Enterprise Division) effective on 2026-05-04. It is very short (228 characters) and contains no financial data, no report, no management or board changes, no voting results, no legal or financing information. It is a regulatory announcement about a change in the company's listing or classification on the exchange. This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2026-04-30 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.